-- Nova Leap Health (NLH.V) 旗下子公司 Earth Angels 周五宣布，已斥资 350 万美元收购了位于新斯科舍省的 Parkwood Home Care。 Nova Leap 在一份声明中表示，公司将以 320 万美元现金支付，并开具一张为期三年、金额为 30 万美元的本票。 交易完成时的现金支付资金来源包括 Nova Leap 收购债务融资额度中的 220 万美元以及公司自有的 100 万美元现金。新增债务的偿还期限为五年。该公司表示，其仍有高达 305 万美元的可用信贷额度。 Parkwood 公布的 2025 财年未经审计的收入为 380 万美元，调整后 EBITDA 为 78.5 万美元。 “新斯科舍省是Nova Leap增长最快的地区，并在2025年取得了创纪录的业绩，”首席执行官克里斯·多宾表示。“Earth Angels收购Parkwood是我们在熟悉的市场中进一步扩大规模的必然之举。此次收购增强了我们高效扩张的能力，深化了我们在该省的业务，并拓展了我们在整个医疗保健服务体系中的作用，从而为我们在新斯科舍省的平台实现持续增长奠定了基础。” 周四，Nova Leap股票在多伦多证券交易所创业板收盘价持平于0.37加元。
Related Articles
Australia
Barclays Adjusts Price Target on Amphenol to $180 From $175
Amphenol (APH) has an average rating of overweight and mean price target of $182.69, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $143.78, Change: $-3.49, Percent Change: -2.37%
$APH
Australia
Piper Sandler Adjusts Arthur J. Gallagher Price Target to $211 From $226
Arthur J. Gallagher & Co (AJG) has an average rating of overweight and mean price target of $272.42, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $214.33, Change: $+7.93, Percent Change: +3.84%
$AJG
Australia
Goldman Sachs Adjusts Price Target on Molson Coors Beverage to $50 From $48
Molson Coors Beverage (TAP) has an average rating of hold and mean price target of $46.15, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $42.37, Change: $-0.38, Percent Change: -0.88%
$TAP